title: Common variable immunodeficiency: the disorder and treatment.
abstract: A case of common variable immunodeficiency, a relatively rare disorder, is presented. This case was complicated by the presence of an anti-IgA antibody in the patient's serum and a history of a possible anaphylactic reaction to a prior intravenous infusion of gamma-globulin. Common variable immunodeficiency is actually a heterogeneous group of demonstrable immunoglobulin deficiencies that have in common low levels of most immunoglobulin isotypes, the inability to form antibodies to antigen, an absence of gross defects in cell-mediated immunity, and the presence of recurrent bacterial infections. The history of immunoglobulin deficiency and its treatment is reviewed. Although the primary therapy for common variable immunodeficiency is gamma-globulin replacement, ancillary measures such as early treatment of infections with antibiotics are also important. Intravenous gamma-globulin replacement therapy is preferred to intramuscular replacement therapy in these patients because intramuscular doses must be limited in volume to minimize local pain and take 2 to 14 days to achieve maximal blood levels, during which time in situ degradation of up to 50% of the administered dose can occur. Five intravenous gamma-globulin preparations are currently available in the United States. The potential adverse effects of intravenous gamma-globulin infusion and the precautions currently taken to ensure safety during administration of this product are discussed.
authors.affiliation: Division of Allergic Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
authors.forename: M W
authors.initials: MW
authors.lastname: Yocum
authors.forename: J M
authors.initials: JM
authors.lastname: Kelso
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007116:Immunization, Passive / Q000009:adverse effects / Q000379:methods; D007153:Immunologic Deficiency Syndromes / Q000628:therapy